Eleven experts. One mission: accelerating the future of Personalised Healthcare in Europe.
The PRECISEU, consortium is proud to announce the creation of our Advisory Board (AB) — a team of 11 distinguished experts from across Europe and the USA who will play a vital role in steering our project toward greater impact and long-term sustainability.
What is PRECISEU?
The general purpose of PRECISEU, the Horizon-Europe funded Regional Innovation Valley on Personalised Medicine, is connecting innovation ecosystems across Europe to efficiently advance towards a truly personalised healthcare. PRECISEU contributes to transferring practices and solutions across the 12 regions participating in the consortium, and scaling up deep-tech healthcare innovations based on advanced therapies medicinal products and health data across Europe.
With a core of coordination and support activities among the 25 partners of he project, and a large cascade funding initiative to support Innovations advance from TRL 6 to 8, the project works to reduce fragmentation and inequalities and accelerate Personalised Medicine in Europe.
Meet our Advisory Board members
The distinguished AB comprises highly qualified professionals with broad strategic views and extensive experience in impactful research, innovation and exploitation of results in Personalised Medicine, with a strong focus on Advanced Therapies, Health Data and Market Access. The AB will act as a strategic think-tank supporting the project’s successful implementation and evolution.
The eleven experts have been carefully selected to ensure a diverse balance in terms of expertise, gender, and geographical representation.
Wolfgang Ballensiefen, Germany
German Aerospace Center – Coordinator of EP Permed
Chair of PRECISEU AB
Focus: Personalised Medicine
EPFIA, European Federation of Pharmaceutical Industries and Associations – Associate Director, Digital & Data for the Science Policy and Regulatory Affairs team
Focus: Industry
Personalized Medicine Coalition – President of PM Coalition
Focus: Personalised Medicine
UNIAMO, Italian Federation of Rare Diseases – President of UNIAMO
Focus: Rare diseases and patient advocacy
Institute for Bioengineering of Catalonia and Catalan Association of Research Centres – Director of IBEC and President of ACER
Focus: Research organisations
Nuria Queralt Rosinach, Netherlands
Leiden University Medical Center- Researcher in Biomedical Informatics and FAIR data
Focus: Health Data
University hospital Freibrug – Director for Institute for Transfusion Medicine and Gene Therapy
Focus: Advanced Therapies
Vilnius University and the National Cancer Institute – Professor of Genetics at VU and Deputy Director for Research and development at the NCI
Focus: Molecular mechanisms of cancer
ATMP Sweden – Head of Unit ATMP Center
Focus: National Advanced Therapies strategies
Stockholm School of Economics – Head of Vision Zero Cancer and Test Bed Sweden
Focus: Impact of Personalised Medicine
SALUT, Catalan Health Service (CatSalut) – Manager of Personalized and Precision Medicine area
Focus: Policymaking for Personalized Medicine
Working closely with the project’s Coordination team and the Work Package leads, the AB will provide valuable insights on the challenges of Personalised Medicine implementation in healthcare across Europe, and recommendations on enhancing the impact and sustainability of project activities.
Throughout the project, five General Assembly Meetings (physical and online) are planned, and in each of them the consortium will invite AB members to receive their guidance and insights. Additionally, the AB members will serve as Ambassadors, actively supporting the dissemination of main project initiatives and results across Europe. Their fresh, independent perspectives will help ensure the relevance, impact and broader connections of PRECISEU, and will ensure that the project’s innovative and impactful results contribute to transforming healthcare.